Celebrating 25 years Est 1999-2024
*Across 3 years $2158.56 only $755.50
Waverley Pharma Acquires US based Pharmacy Canada NewsWire WINNIPEG, MB, Sept. 23, 2024 WINNIPEG, MB, Sept. 23, 2024 /CNW/ - Waverley Pharma Inc...
Waverley Pharma Announces Annual and Special Meeting Election Results Canada NewsWire WINNIPEG, MB, June 20, 2024 WINNIPEG, MB, June 20, 2024...
Waverley Pharma Business Update Canada NewsWire WINNIPEG, MB, April 30, 2024 WINNIPEG, MB, April 30, 2024 /CNW/ - Waverley Pharma Inc...
Waverley Pharma Announces Changes to Board of Directors Canada NewsWire WINNIPEG, MB, Nov. 22, 2023 WINNIPEG, MB, Nov. 22, 2023 /CNW/ - Waverley...
Waverley Pharma Business Update Canada NewsWire WINNIPEG, MB, Aug. 2, 2023 WINNIPEG, MB, Aug. 2, 2023 /CNW/ - Waverley Pharma Inc...
Waverley Pharma Provides Business Update Canada NewsWire WINNIPEG, MB, March 20, 2023 WINNIPEG, MB, March 20, 2023 /CNW/ - Waverley Pharma Inc...
Waverley Pharma Provides Update on its PARP-1 Inhibitor Program Canada NewsWire WINNIPEG, MB, Jan. 11, 2023 WINNIPEG, MB, Jan. 11, 2023 /CNW/...
Waverley Pharma Announces $3,000,000 Credit Facility Canada NewsWire WINNIPEG, MB, Aug. 5, 2021 WINNIPEG, MB, Aug. 5, 2021 /CNW/ - Waverley...
Waverley Pharma Announces Successful Tender Award for Pemetrexed with NHS England Canada NewsWire WINNIPEG, MB, May 27, 2021 WINNIPEG, MB, May...
Waverley Pharma Announces Successful Tender Award for Capecitabine with NHS Scotland Canada NewsWire WINNIPEG, MB, Jan. 18, 2021 WINNIPEG, MB...
Waverley Pharma Announces Tentative ANDA Approval for Pemetrexed in the United States Canada NewsWire WINNIPEG, MB, Nov. 12, 2020 WINNIPEG, MB...
Waverley Pharma Announces Listing on the Frankfurt Stock Exchange (FSE: 5GZ) Canada NewsWire WINNIPEG, MB, Sept. 23, 2020 WINNIPEG, MB, Sept. 23...
Waverley Pharma Announces Signing of Term Sheet to Acquire Exclusive Rights to Market Six Generic Oncology Products in the United States Canada...
Waverley Pharma Announces Grant of Market Authorization for Pemetrexed in Spain and Bortezomib in Italy Canada NewsWire WINNIPEG, MB, Aug. 25...
Waverley Pharma Announces Grant of Market Authorization for Pemetrexed and Bortezomib in Multiple European Countries Canada NewsWire WINNIPEG...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.